|
RPUSD4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.206350E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.875600E-02 |
| Normal-vs-Stage2 |
3.684200E-01 |
| Normal-vs-Stage3 |
9.814100E-02 |
| Normal-vs-Stage4 |
5.858800E-01 |
| Stage1-vs-Stage2 |
6.618600E-01 |
| Stage1-vs-Stage3 |
7.511800E-01 |
| Stage1-vs-Stage4 |
1.228990E-01 |
| Stage2-vs-Stage3 |
5.047400E-01 |
| Stage2-vs-Stage4 |
3.661200E-01 |
| Stage3-vs-Stage4 |
1.289760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.295360E-01 |
| Normal-vs-AfricanAmerican |
6.591200E-01 |
| Normal-vs-Asian |
5.737600E-02 |
| Caucasian-vs-AfricanAmerican |
4.419400E-01 |
| Caucasian-vs-Asian |
4.417800E-01 |
| AfricanAmerican-vs-Asian |
3.416400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.290400E-02 |
| Normal-vs-Female |
8.502600E-01 |
| Male-vs-Female |
4.594200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.314800E-01 |
| Normal-vs-Extreme_Weight |
6.121800E-03 |
| Normal-vs-Obese |
9.998600E-01 |
| Normal-vs-Extreme_Obese |
7.374000E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.305830E-01 |
| Normal_Weight-vs-Obese |
8.518200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.316000E-01 |
| Extreme_Weight-vs-Obese |
3.976100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.408200E-01 |
| Obese-vs-Extreme_Obese |
1.398960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.962800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.819000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.401600E-02 |
| Normal-vs-Age(81-100Yrs) |
1.849240E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.359000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.696440E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.557980E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.322200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.900600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.824200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.151600E-02 |
| Normal-VS-Type2 PRCC |
6.166600E-01 |
| Normal-VS-KIRP CIMP |
9.785600E-01 |
| Normal-VS-Unclassified PRCC |
4.702800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.886400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.317600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.491400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.470800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.074600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.691600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.587200E-01 |
| Normal-vs-N1 |
6.759400E-01 |
| Normal-vs-N2 |
5.502200E-01 |
| N0-vs-N1 |
8.213800E-01 |
| N0-vs-N2 |
9.361400E-01 |
| N1-vs-N2 |
8.666800E-01 |
|
|
